This page is part of the HL7 FHIR Implementation Guide: minimal Common Oncology Data Elements (mCODE) Release 1 - US Realm | STU1 (v1.16.0: STU 2 Ballot 1) based on FHIR R4. The current version which supercedes this version is 2.0.0. For a full list of available versions, see the Directory of published versions
Generated Narrative
Treatment Intent: Curative - procedure intent
Termination Reason: Treatment completed (situation)
status: active
intent: order
medication: CISplatin 50 MG per 50 ML Injectable Solution
authoredOn: 2019-04-01
requester: Generated Summary: id: 9988776655; Kyle Anydoc ; gender: male
reasonCode: Non-small cell lung cancer (disorder)
note: Day 1 of NSCLC regimen: Cisplatin 75 mg/m2 day 1; docetaxel 75 mg/m2 day 1 every 21 days for 4 cycles.
- |
* |